186 related articles for article (PubMed ID: 36291603)
1. Leveraging the Structure of DNAJA1 to Discover Novel Potential Pancreatic Cancer Therapies.
Roth HE; De Lima Leite A; Palermo NY; Powers R
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291603
[TBL] [Abstract][Full Text] [Related]
2. Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancer.
Stark JL; Mehla K; Chaika N; Acton TB; Xiao R; Singh PK; Montelione GT; Powers R
Biochemistry; 2014 Mar; 53(8):1360-72. PubMed ID: 24512202
[TBL] [Abstract][Full Text] [Related]
3. DNAJA1 Dysregulates Metabolism Promoting an Antiapoptotic Phenotype in Pancreatic Ductal Adenocarcinoma.
Roth HE; Bhinderwala F; Franco R; Zhou Y; Powers R
J Proteome Res; 2021 Aug; 20(8):3925-3939. PubMed ID: 34264680
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mutant Kras and p53-driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53.
Xu D; Tong X; Sun L; Li H; Jones RD; Liao J; Yang GY
Mol Carcinog; 2019 Nov; 58(11):2052-2064. PubMed ID: 31397499
[TBL] [Abstract][Full Text] [Related]
5. Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2.
Ergülen E; Bécsi B; Csomós I; Fésüs L; Kanchan K
Biochem J; 2016 Nov; 473(21):3889-3901. PubMed ID: 27551108
[TBL] [Abstract][Full Text] [Related]
6. Identification of a druggable protein-protein interaction site between mutant p53 and its stabilizing chaperone DNAJA1.
Tong X; Xu D; Mishra RK; Jones RD; Sun L; Schiltz GE; Liao J; Yang GY
J Biol Chem; 2021; 296():100098. PubMed ID: 33208462
[TBL] [Abstract][Full Text] [Related]
7. DnaJA1/Hsp40 is co-opted by influenza A virus to enhance its viral RNA polymerase activity.
Cao M; Wei C; Zhao L; Wang J; Jia Q; Wang X; Jin Q; Deng T
J Virol; 2014 Dec; 88(24):14078-89. PubMed ID: 25253355
[TBL] [Abstract][Full Text] [Related]
8. DNAJA1 promotes cancer metastasis through interaction with mutant p53.
Kaida A; Yamamoto S; Parrales A; Young ED; Ranjan A; Alalem MA; Morita KI; Oikawa Y; Harada H; Ikeda T; Thomas SM; Diaz FJ; Iwakuma T
Oncogene; 2021 Aug; 40(31):5013-5025. PubMed ID: 34183772
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein DNAJA1 stabilizes PIWI proteins to support regeneration and homeostasis of planarian
Wang C; Yang ZZ; Guo FH; Shi S; Han XS; Zeng A; Lin H; Jing Q
J Biol Chem; 2019 Jun; 294(25):9873-9887. PubMed ID: 31076507
[TBL] [Abstract][Full Text] [Related]
10. DNAJA1- and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screen.
Nishikawa S; Kaida A; Parrales A; Ranjan A; Alalem M; Ren H; Schoenen FJ; Johnson DK; Iwakuma T
Cell Death Discov; 2022 Oct; 8(1):437. PubMed ID: 36316326
[TBL] [Abstract][Full Text] [Related]
11. Druggable sites/pockets of the p53-DNAJA1 protein-protein interaction: In silico modeling and in vitro/in vivo validation.
Jacobsen D; Bushara O; Mishra RK; Sun L; Liao J; Yang GY
Methods Enzymol; 2022; 675():83-107. PubMed ID: 36220282
[TBL] [Abstract][Full Text] [Related]
12. Dealing with difficult clients via personalized chaperone inhibitors.
Truman AW
J Biol Chem; 2021; 296():100211. PubMed ID: 33837724
[TBL] [Abstract][Full Text] [Related]
13. Optimal functional levels of activation-induced deaminase specifically require the Hsp40 DnaJa1.
Orthwein A; Zahn A; Methot SP; Godin D; Conticello SG; Terada K; Di Noia JM
EMBO J; 2012 Feb; 31(3):679-91. PubMed ID: 22085931
[TBL] [Abstract][Full Text] [Related]
14. High expression of
Ileri FC; Acun T
Biomark Med; 2021 Aug; 15(12):941-950. PubMed ID: 34236236
[No Abstract] [Full Text] [Related]
15. DNAJA1 promotes proliferation and metastasis of breast cancer by activating mutant P53/NF-κB pathway.
Wu J; Yang Q; Zhu Y; Xia T; Yi L; Wang J; Ren X
Pathol Res Pract; 2023 Dec; 252():154921. PubMed ID: 37977037
[TBL] [Abstract][Full Text] [Related]
16. DnaJA1 antagonizes constitutive Hsp70-mediated stabilization of tau.
Abisambra JF; Jinwal UK; Suntharalingam A; Arulselvam K; Brady S; Cockman M; Jin Y; Zhang B; Dickey CA
J Mol Biol; 2012 Aug; 421(4-5):653-61. PubMed ID: 22343013
[TBL] [Abstract][Full Text] [Related]
17. The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones.
Qiu XB; Shao YM; Miao S; Wang L
Cell Mol Life Sci; 2006 Nov; 63(22):2560-70. PubMed ID: 16952052
[TBL] [Abstract][Full Text] [Related]
18. KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis.
Yang S; Ren X; Liang Y; Yan Y; Zhou Y; Hu J; Wang Z; Song F; Wang F; Liao W; Liao W; Ding Y; Liang L
Oncogene; 2020 Jan; 39(2):249-261. PubMed ID: 31477839
[TBL] [Abstract][Full Text] [Related]
19. Chemogenomic screening identifies the Hsp70 co-chaperone DNAJA1 as a hub for anticancer drug resistance.
Nitika ; Blackman JS; Knighton LE; Takakuwa JE; Calderwood SK; Truman AW
Sci Rep; 2020 Aug; 10(1):13831. PubMed ID: 32796891
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin.
Alalem M; Bhosale M; Ranjan A; Yamamoto S; Kaida A; Nishikawa S; Parrales A; Farooki S; Anant S; Padhye S; Iwakuma T
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
